IRX4204
IRX4204Psoriasis201
Phase 2 small_molecule on_hold
Quick answer
IRX4204 for Psoriasis is a Phase 2 program (small_molecule) at IO Biotech with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IO Biotech
- Indication
- Psoriasis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- on_hold